Skip to content

Drug interactions

Ivosidenib + Ranolazine

Severity: Major

Ivosidenib and Ranolazine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivosidenib prolongs the QTc interval and so does ranolazine, so the combination may raise arrhythmia risk. Ivosidenib also induces CYP3A4, which may lower ranolazine concentrations and reduce antianginal effect.

What this interaction means in plain words

Ivosidenib and Ranolazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ivosidenib belongs to Oncology; Ranolazine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive QT prolongation plus CYP3A4 induction by ivosidenib reducing ranolazine exposure.

What to do

Avoid the combination where possible and use an alternative antianginal. If unavoidable, monitor ECG and electrolytes and assess angina control.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ivosidenib and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ivosidenib with Ranolazine?

MediHelp rates the interaction as major. Ivosidenib and Ranolazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ivosidenib prolongs the QTc interval and so does ranolazine, so the combination may raise arrhythmia risk. Ivosidenib also induces CYP3A4, which may lower ranolazine concentrations and reduce antianginal effect.

How serious is the interaction between Ivosidenib and Ranolazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and use an alternative antianginal. If unavoidable, monitor ECG and electrolytes and assess angina control.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in